What is the formula for calculating drug clearance?

The formula for total drug clearance is based on the relationship between clearance, volume of distribution, and the elimination rate constant. Total clearance equals the volume of distribution multiplied by the elimination rate constant. Clearance is also calculated as the elimination rate divided by the drug concentration in body fluid. The formulas are: $Cl_t = V_d \times k_{el}$ and $Cl_t = \frac{\text{Elimination Rate}}{C}$. Clearance represents the theoretical volume of blood plasma or biological fluid completely cleared of a drug per unit of time.

How is the volume of distribution of a drug calculated?

Within a single-compartment model, the volume of distribution is calculated as the ratio of the administered dose to the initial concentration: $V_d = \frac{D}{C_0}$. Here $V_d$ is the volume of distribution, $D$ is the administered dose, and $C_0$ is the initial concentration immediately after distribution.

Why does the plasma concentration of a drug drop so sharply at first?

This is due to the $\alpha$-phase. The substance is not yet eliminated from the body, but is rapidly redistributed from plasma into peripheral compartment tissues.

Which parameter do reference books usually denote as $t_{1/2}$?

Typically, $t_{1/2}$ refers to the elimination half-life ($t_{1/2}\beta$). It characterizes the slow phase of true drug elimination rather than initial distribution.

What does an elimination constant of $0.05\text{ h}^{-1}$ mean?

This means that exactly 5% of the drug amount currently circulating in the body is eliminated every hour.

Home › Pharmacology › Distribution and Elimination Phases

Distribution and Elimination Phases

For medical students2 min readUpdated 2026-10-10

After administration, a drug undergoes two key phases: rapid tissue distribution followed by slow elimination. These processes are described by a two-compartment pharmacokinetic model, which divides the body into central and peripheral pools. Understanding these phases is essential for evaluating how quickly a drug will take effect and when it will be completely cleared from the body.

Central compartmentPlasma and highly perfused organs (heart, liver, kidneys, lungs).

Peripheral compartmentTissues with lower perfusion (skin, muscles, adipose tissue).

Phase speedDistribution (alpha phase) is always faster than elimination (beta phase).

Kel constantReflects the fraction of the drug eliminated from the body per unit of time.

Anatomical Structure of Compartments in Pharmacokinetics

To understand how a drug behaves inside the body, pharmacologists use special models. The most popular one divides all organs and tissues into two large groups, or "compartments," depending on how intensely they are supplied with blood.

Central compartment. This includes blood plasma itself, as well as organs receiving the maximum cardiac output. These traditionally include the heart (cor), liver (hepar), kidneys (renes), and lungs (pulmones). The main characteristic of this compartment is that any drug distributes here almost instantaneously. As soon as the drug enters the systemic circulation, it immediately and evenly fills the entire volume of the central pool.
Peripheral compartment. This includes tissues with less intense blood supply. These are the skin (cutis), adipose tissue, and skeletal muscle (musculi). Unlike the central pool, the drug penetrates these anatomical structures not immediately, but gradually.

$\alpha$-Phase (Distribution Phase)

Upon administration, any drug begins to move. The first stage of this movement is called the $\alpha$-phase, or the distribution phase.

At this stage, the direction of molecular transport is strictly defined: the substance actively moves from the central compartment to the peripheral compartment. Looking at the plasma drug concentration curve, we see a very rapid and sharp drop. It is important to understand that this drop occurs not because the drug has left the body, but solely due to the shift of the substance from plasma into less perfused tissues.

This process is described by a special pharmacokinetic parameter — the half-distribution time, denoted as $t_{1/2}\alpha$. The key feature of this phase is its high speed. Distribution is always significantly faster than the subsequent elimination of the drug. Mathematically, this is expressed by the strict inequality: $t_{1/2}\alpha < t_{1/2}\beta$.

$\beta$-Phase (Elimination Phase)

Once the tissues of the peripheral compartment are saturated with the drug, the second stage begins — the $\beta$-phase, also known as the elimination phase.

Now the direction of transport reverses dramatically. The drug begins to move backward: it shifts from the peripheral compartment back to the central compartment, from which it is ultimately cleared from the body.

During this stage, the decrease in plasma drug concentration is very slow. This phase reflects true elimination (clearance) of the xenobiotic from the body. The main parameter here is the elimination half-life, denoted as $t_{1/2}\beta$. A practical detail worth noting: when opening a medical reference book and seeing the parameter $t_{1/2}$, in the overwhelming majority of cases, it refers to the elimination half-life rather than distribution.

Elimination Rate Constant ($k_{el}$)

To quantitatively describe drug removal, pharmacology uses the elimination rate constant, or $k_{el}$.

Its physical meaning is very concrete: it shows what fraction of the substance is removed from the body per unit of time. The dimension of this indicator is expressed in reciprocal time — for example, inverse minutes ($ ext{min}^{-1}$) or inverse hours ($ ext{h}^{-1}$).

Calculation Example: Suppose for a certain drug the elimination rate constant $k_{el}$ is $0.1\text{ h}^{-1}$. Practically, this means that exactly 10% of the amount of substance present in the body at the beginning of that hour will be eliminated within one hour.

Mnemonic

To avoid confusing the direction of molecular movement: Alpha-phase — Active departure into tissues (from blood to the periphery). Beta-phase — Bailing out of the body (return from the periphery to the blood and final elimination).

Frequently asked questions

What is the formula for calculating drug clearance?: The formula for total drug clearance is based on the relationship between clearance, volume of distribution, and the elimination rate constant. Total clearance equals the volume of distribution multiplied by the elimination rate constant. Clearance is also calculated as the elimination rate divided by the drug concentration in body fluid. The formulas are: $Cl_t = V_d \times k_{el}$ and $Cl_t = \frac{\text{Elimination Rate}}{C}$. Clearance represents the theoretical volume of blood plasma or biological fluid completely cleared of a drug per unit of time.
How is the volume of distribution of a drug calculated?: Within a single-compartment model, the volume of distribution is calculated as the ratio of the administered dose to the initial concentration: $V_d = \frac{D}{C_0}$. Here $V_d$ is the volume of distribution, $D$ is the administered dose, and $C_0$ is the initial concentration immediately after distribution.
Why does the plasma concentration of a drug drop so sharply at first?: This is due to the $\alpha$-phase. The substance is not yet eliminated from the body, but is rapidly redistributed from plasma into peripheral compartment tissues.
Which parameter do reference books usually denote as $t_{1/2}$?: Typically, $t_{1/2}$ refers to the elimination half-life ($t_{1/2}\beta$). It characterizes the slow phase of true drug elimination rather than initial distribution.
What does an elimination constant of $0.05\text{ h}^{-1}$ mean?: This means that exactly 5% of the drug amount currently circulating in the body is eliminated every hour.

Go deeper

Anatomical features of central compartment organs
Mechanisms of gradual drug penetration into peripheral compartment tissues
Clinical significance of the half-distribution time ($t_{1/2}\alpha$)
Mathematical calculation of the elimination rate constant ($k_{el}$)
Comparison of $\alpha$- and $\beta$-phase kinetics